Skip Navigation



Cerebral Cortex Advance Access published online on February 8, 2006
Cerebral Cortex, doi:10.1093/cercor/bhj136
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/1/175    most recent
bhj136v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Eggan, S. M.
Right arrow Articles by Lewis, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eggan, S. M.
Right arrow Articles by Lewis, D. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Article

Immunocytochemical Distribution of the Cannabinoid CB1 Receptor in the Primate Neocortex: A Regional and Laminar Analysis

Stephen M. Eggan 1 and David A. Lewis 2 *

1 Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15213, USA; Center for the Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, PA 15213, USA
2 Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15213, USA

* To whom correspondence should be addressed.
David A. Lewis, E-mail: lewisda{at}upmc.edu


  Abstract

Delta-9-tetrahydrocannabinol ({Delta}9-THC) has profound effects on higher cognitive functions, and exposure to {Delta}9-THC has been associated with the appearance or exacerbation of the clinical features of schizophrenia. These actions appear to be mediated via the CB1 receptor, the principal cannabinoid receptor expressed in the brain. However, the distribution of the CB1 receptor in neocortical regions of the primate brain that mediate cognitive functions is not known. We therefore investigated the immunocytochemical localization of the CB1 receptor in the brains of macaque monkeys and humans using antibodies that specifically recognize the N- or C-terminus of the CB1 receptor. In monkeys, intense CB1 immunoreactivity was observed primarily in axons and boutons. Across neocortical regions of the monkey brain, CB1-immunoreactive (IR) axons exhibited considerable heterogeneity in density and laminar distribution. Neocortical association regions, such as the prefrontal and cingulate cortices, demonstrated a higher density, and exhibited a unique laminar pattern of CB1-IR axons, compared with primary sensory and motor cortices. Similar regional and laminar distributions of CB1-IR axons were also present in the human neocortex. CB1-IR axons had more prominent varicosities in human tissue, but this difference appeared to represent a postmortem effect as similar morphological features increased in unperfused monkey tissue as a function of postmortem interval. In electron microscopy studies of perfused monkey prefrontal cortex, CB1 immunoreactivity was predominantly found in axon terminals that exclusively formed symmetric synapses. The high density, distinctive laminar distribution, and localization to inhibitory terminals of CB1 receptors in primate higher-order association regions suggests that the CB1 receptor may play a critical role in the circuitry that subserves cognitive functions such as those that are disturbed in schizophrenia.

Keywords: cholecystokinin; GABA; human; interneurons; monkey; parvalbumin.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cereb CortexHome page
S. M. Eggan, Y. Mizoguchi, S. R. Stoyak, and D. A. Lewis
Development of Cannabinoid 1 Receptor Protein and Messenger RNA in Monkey Dorsolateral Prefrontal Cortex
Cereb Cortex, August 24, 2009; (2009) bhp179v1.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
A. V. Zaitsev, N. V. Povysheva, G. Gonzalez-Burgos, D. Rotaru, K. N. Fish, L. S. Krimer, and D. A. Lewis
Interneuron Diversity in Layers 2-3 of Monkey Prefrontal Cortex
Cereb Cortex, July 1, 2009; 19(7): 1597 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
K. H. Taber and R. A. Hurley
Endocannabinoids: Stress, Anxiety, and Fear
J Neuropsychiatry Clin Neurosci, May 1, 2009; 21(2): iv - 113.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev, January 1, 2009; 89(1): 309 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
S. M. Eggan, T. Hashimoto, and D. A. Lewis
Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Arch Gen Psychiatry, July 1, 2008; 65(7): 772 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. Freedman
Cannabis, Inhibitory Neurons, and the Progressive Course of Schizophrenia
Am J Psychiatry, April 1, 2008; 165(4): 416 - 419.
[Full Text] [PDF]

Home page
 Cereb CortexHome page
E. Carter and X.-J. Wang
Cannabinoid-Mediated Disinhibition and Working Memory: Dynamical Interplay of Multiple Feedback Mechanisms in a Continuous Attractor Model of Prefrontal Cortex
Cereb Cortex, September 1, 2007; 17(suppl_1): i16 - i26.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.